Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Hypertens Res ; 27(12): 939-46, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15894834

RESUMO

To assess the relationship between home blood pressure and left ventricular mass, we evaluated cardiac echocardiography in 297 hypertensive subjects (188 men and 109 women; mean age, 62.8+/-10.3 years) who were treated with amlodipine monotherapy over 1 year (mean dose, 5.5+/-2.3 mg/day). The morning hypertension group (n=57; 19.2%), who had a morning home systolic blood pressure (HSBP) > or =135 mmHg and an evening HSBP <135 mmHg, had a significantly greater left ventricular mass index (LVMI) concomitant with an increase in the homeostasis model assessment insulin resistance index (HOMA-IR) compared to the good control group (n=174; 58.6%), whose morning and evening HSBP were both <135 mmHg, and had a LVMI roughly equivalent to that of the poor control group (n=63; 21.2%), whose morning and evening HSBP were both > or =135 mmHg. By grouping of subjects according to the difference between morning and evening HSBP (delta HSBP), subjects with a delta HSBP> or =10 mmHg had a significantly greater LVMI than subjects with a delta HSBP <10 mmHg. Increases in LVMI in these patients were still significant after adjustment for age, gender, dose of amlodipine, alcohol consumption, body mass index, office systolic blood pressure, and morning and evening HSBP. In a stepwise multivariate regression analysis, delta HSBP (r2=36.2%, p <0.001), morning HSBP (r2=5.5%, p <0.001), HOMA-IR (r2=1.4%, p=0.016) and age (r2=1.0%, p=0.026) were determined to be significant contributing factors for LVMI. This regression model could explain 44.1% of LVMI variability. These results suggest that morning rise in blood pressure is a dominant predictor of left ventricular hypertrophy.


Assuntos
Ciclos de Atividade , Pressão Sanguínea , Hipertensão/complicações , Hipertrofia Ventricular Esquerda/diagnóstico por imagem , Idoso , Anlodipino/uso terapêutico , Monitorização Ambulatorial da Pressão Arterial , Bloqueadores dos Canais de Cálcio/uso terapêutico , Feminino , Humanos , Hipertensão/diagnóstico por imagem , Hipertensão/tratamento farmacológico , Hipertrofia Ventricular Esquerda/epidemiologia , Resistência à Insulina , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Ultrassonografia
2.
Ryumachi ; 43(3): 577-82, 2003 Jun.
Artigo em Japonês | MEDLINE | ID: mdl-12910968

RESUMO

We report a case of adult onset Still's disease in a 77 year old man, who was diagnosed as a esophageal cancer 9 months after the onset of this disease. At first malignant lesions in any organs were not found and steroid (prednisolone) therapy was begun and the patient was recovered from manifestations. But while tapering prednisolone to 15 mg, fever, arthritis and rash were observed again. Repeated examination revealed that he had suffered from esophageal cancer. This case is considered as a paraneoplastic syndrome of the esophageal cancer. Patients with adult onset Still's disease should be followed as a paraneoplastic syndrome.


Assuntos
Neoplasias Esofágicas/diagnóstico , Síndromes Paraneoplásicas/diagnóstico , Doença de Still de Início Tardio/diagnóstico , Idoso , Anti-Inflamatórios/administração & dosagem , Neoplasias Esofágicas/etiologia , Humanos , Masculino , Prednisolona/administração & dosagem , Doença de Still de Início Tardio/complicações , Doença de Still de Início Tardio/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA